Methylation of the GSTM5 promoter region has also been reported in several malignant tumors, including bladder cancer, Barrett's adenocarcinoma and thyroid carcinoma [13, 22, 38]. The gene discussed is GSTM5; the disease is Barrett adenocarcinoma.